<?xml version="1.0" encoding="UTF-8"?>
<p id="p0060">Enhanced supportive care remains the mainstay of treatment. More than 300 clinical trials for drugs have been conducted, some of which will be published in the coming months. WHO launched the 
 <italic>Solidarity</italic> clinical trial for COVID-19 treatment to further evaluate remdesivir, hydroxychloroquine/chloroquine and lopinavir-ritonavir with and without interferon-Î². However, various other antiviral agents and immunomodulators are being evaluated for use at various stages of COVID-19. The registry of international clinical trials can be found on the WHO website and at ClinicalTrials.gov [
 <xref rid="bib35" ref-type="bibr">35</xref>]. Currently, it is strongly recommended to recruit patients to participate in ongoing trials because we cannot determine whether the benefits of most treatments outweigh the hazards, and these studies will provide much-needed evidence for the efficacy and safety of various treatments for COVID-19 [
 <xref rid="bib36" ref-type="bibr">36</xref>].
</p>
